T0070907
目录号: A11588
PPAR-γ 拮抗剂
T0070907 被确认为一种强效且选择性的 PPARgamma 拮抗剂。其表观结合亲和力(50%抑制[(3)H]罗格列酮结合的浓度或 IC(50))为1纳摩尔,T0070907 在人类 PPARgamma2 的螺旋3上的半胱氨酸313位点与 PPARgamma 形成共价修饰。
| Discription | T0070907 was identified as a potent and selective PPARgamma antagonist. With an apparent binding affinity (concentration at 50% inhibition of [(3)H]rosiglitazone binding or IC(50)) of 1 nm, T0070907 covalently modifies PPARgamma on cysteine 313 in helix 3 of human PPARgamma2. | ||
|---|---|---|---|
| Targets |
|
| 目录号 | A11588 |
|---|---|
| 分子式 | C12H8ClN3O3 |
| 分子量 | 277.66 |
| CAS号 | 313516-66-4 |
| SMILES | ClC1=CC=C([N+]([O-])=O)C=C1C(NC2=CC=NC=C2)=O |
| 其他名称 | T 0070907 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro (25°C) | DMSO | 24 mg/mL (86.43 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 5% DMSO+45% PEG 300+ddH2O | 8 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 36.02 mL | 180.08 mL | 360.15 mL |
| 0.5 mM | 7.2 mL | 36.02 mL | 72.03 mL |
| 1 mM | 3.6 mL | 18.01 mL | 36.02 mL |
| 5 mM | 0.72 mL | 3.6 mL | 7.2 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2